Elevated globotriaosylsphingosine is a hallmark of Fabry disease

Amsterdam UMC Location University of Amsterdam · Endocrinology Research Center · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Fabry disease is an X-linked lysosomal storage disease caused by deficiency of alpha-galactosidase A that affects males and shows disease expression in heterozygotes. The characteristic progressive renal insufficiency, cardiac involvement, and neuropathology usually are ascribed to globotriaosylceramide accumulation in the endothelium. However, no direct correlation exists between lipid storage and clinical manifestations, and treatment of patients with recombinant enzymes does not reverse several key signs despite clearance of lipid from the endothelium. We therefore investigated the possibility that globotriaosylceramide metabolites are a missing link in the pathogenesis. We report that deacylated…

Citation impact

723
total citations
FWCI
18.13
Percentile
100%
References
50
Citations per year

Authors

18

Topics & keywords

Keywords
  • Globotriaosylceramide
  • Fabry disease
  • Fabry's disease
  • Sphingolipid
  • Enzyme replacement therapy
  • Metabolite
  • Pathogenesis
  • Endocrinology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.